'Corrigendum to "Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia" [Molecular Metabolism 5 (2) (2015) 67-78]'
Mol Metab. 2020 May:35:100970.
doi: 10.1016/j.molmet.2020.02.013.
Epub 2020 Mar 4.
1 Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, 85764, Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine I, Heidelberg University Hospital, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany; German Center for Diabetes Research (DZD), 85764, Neuherberg, Germany.
2 Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany; Department of Molecular Cardiology and Epigenetics, University Hospital Heidelberg, 69120, Heidelberg, Germany.
3 Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, 85764, Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine I, Heidelberg University Hospital, 69120, Heidelberg, Germany; German Center for Diabetes Research (DZD), 85764, Neuherberg, Germany.
4 Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany.
5 Division of Signaling and Functional Genomics, German Cancer, Research Center (DKFZ), 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany.
6 Center for Medical Research, University of Mannheim, 68167, Mannheim, Germany.
7 Department for Cell Signaling and Mass Spectrometry, Max Delbrück Center, 13092, Berlin, Germany.
8 Department of Experimental and Clinical Pharmacology and Toxicology, University Medical Center, 20246, Hamburg-Eppendorf, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Hamburg/Kiel/Lübeck, 20246, Hamburg-Eppendorf, Germany.
9 Core Facility Tumor Models, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
10 Department of, General Surgery, University of Heidelberg, 69120, Heidelberg, Germany.
11 Genome Biology Unit, EMBL, 69117, Heidelberg, Germany.
12 Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany; Department of Molecular Cardiology and Epigenetics, University Hospital Heidelberg, 69120, Heidelberg, Germany. Electronic address: johannes.backs@med.uni-heidelberg.de.
13 Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, 85764, Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine I, Heidelberg University Hospital, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany; German Center for Diabetes Research (DZD), 85764, Neuherberg, Germany. Electronic address: stephan.herzig@helmholtz-muenchen.de.